This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., The Broad Institute, Inc., The General Hospital Corporation. Active years: 2018-2026.
Company Filing History:
3 out of 1,264 
2 out of 480 
1 out of 3,068 
Years Active: 2018-2026
Title: Bjoern Chapuy: Innovator in Cancer Therapy
Introduction
Bjoern Chapuy is a prominent inventor based in Boston, MA (US), known for his significant contributions to cancer therapy. With a focus on innovative treatments, he has been awarded 3 patents that showcase his expertise in the field of oncology.
Latest Patents
Chapuy's latest patents include groundbreaking methods for treating cancer using combinations of bromodomain and extra-terminal (BET) protein inhibitors. This invention provides novel approaches to enhance the efficacy of certain chemotherapeutic drugs. Additionally, he has developed compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer, particularly hematological malignancies in humans. These inventions involve a variety of biomarker chromosomal number alterations (CNAs) that are associated with cancer status, offering new avenues for detection and treatment.
Career Highlights
Throughout his career, Bjoern Chapuy has worked with esteemed organizations such as Dana-Farber Cancer Institute and The Broad Institute. His work in these institutions has allowed him to collaborate with leading experts in the field, further advancing cancer research and treatment methodologies.
Collaborations
Some of his notable coworkers include Margaret A. Shipp and James Elliott Bradner, who have played significant roles in his research endeavors.
Conclusion
Bjoern Chapuy's innovative work in cancer therapy exemplifies the impact of dedicated research and invention in the medical field. His contributions continue to pave the way for advancements in cancer treatment and patient care.